Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binghe Xu

Showing results (31-40 of 406) with videos related to

Pageof 41
Sort By:
Biomed Research International|June 14, 2021
Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast CancerYiqun Han, Jiayu Wang, Binghe Xu
Critical Reviews in Oncology/Hematology|June 4, 2021
Cutaneous adverse events associated with immune checkpoint blockade: A systematic review and meta-analysisYiqun Han, Jiayu Wang, Binghe Xu
Peerj|March 4, 2025
Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancerYimin Zhu, Jiayu Wang, Binghe Xu
Cancer Innovation|December 13, 2023
The road toward breast cancer single-disease quality control in ChinaBo Lan, Qiao Li, Fei Ma, et al.
Current Problems in Cancer|May 25, 2020
Comparative efficacy and safety of CDK4/6 and PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and network meta-analysisYiqun Han, Jiayu Wang, Zijing Wang, et al.
Frontiers in Oncology|March 15, 2021
Sex-Based Heterogeneity in the Clinicopathological Characteristics and Prognosis of Breast Cancer: A Population-Based AnalysisYiqun Han, Jiayu Wang, Zijing Wang, et al.
Plos One|October 30, 2015
Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment ModalitiesRuoxi Hong, Zhen Dai, Wenjie Zhu, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 16, 2021
Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based AnalysisYiqun Han, Jiayu Wang, Zijing Wang, et al.
International Journal of Cancer|June 14, 2023
The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 statusMingxia Jiang, Jiaxuan Liu, Qiao Li, et al.
Expert Review of Anticancer Therapy|October 15, 2020
Metronomic therapy in advanced breast cancer and NSCLC: vinorelbine as a paradigm of recent progressBinghe Xu, Tao Sun, Shusen Wang, et al.
Pageof 41

Showing results (31-40 of 406) with videos related to

Sort By:
Pageof 41
Biomed Research International|June 14, 2021
Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast CancerYiqun Han, Jiayu Wang, Binghe Xu
Critical Reviews in Oncology/Hematology|June 4, 2021
Cutaneous adverse events associated with immune checkpoint blockade: A systematic review and meta-analysisYiqun Han, Jiayu Wang, Binghe Xu
Peerj|March 4, 2025
Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancerYimin Zhu, Jiayu Wang, Binghe Xu
Cancer Innovation|December 13, 2023
The road toward breast cancer single-disease quality control in ChinaBo Lan, Qiao Li, Fei Ma, et al.
Current Problems in Cancer|May 25, 2020
Comparative efficacy and safety of CDK4/6 and PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and network meta-analysisYiqun Han, Jiayu Wang, Zijing Wang, et al.
Frontiers in Oncology|March 15, 2021
Sex-Based Heterogeneity in the Clinicopathological Characteristics and Prognosis of Breast Cancer: A Population-Based AnalysisYiqun Han, Jiayu Wang, Zijing Wang, et al.
Plos One|October 30, 2015
Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment ModalitiesRuoxi Hong, Zhen Dai, Wenjie Zhu, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 16, 2021
Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based AnalysisYiqun Han, Jiayu Wang, Zijing Wang, et al.
International Journal of Cancer|June 14, 2023
The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 statusMingxia Jiang, Jiaxuan Liu, Qiao Li, et al.
Expert Review of Anticancer Therapy|October 15, 2020
Metronomic therapy in advanced breast cancer and NSCLC: vinorelbine as a paradigm of recent progressBinghe Xu, Tao Sun, Shusen Wang, et al.
Pageof 41